ReviewFrontiers in nutrition2026
Beyond a universal obesity microbiome signature: pre-intervention heterogeneity and a framework for baseline profiling.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Unlike previous reviews that primarily summarize obesity-associated microbial alterations, this review reframes the recurrent inconsistency of human obesity microbiome findings as an informative consequence of pre-intervention heterogeneity rather than merely failed replication or analytical noise. We integrate biological and contextual determinants of baseline microbiota variation with methodological and analytical sources of heterogeneity into a unified framework for interpreting why microbial diversity, taxonomic composition, and functional signals differ across individuals, populations, and studies. We critically synthesize evidence on baseline microbial diversity, community structure, host characteristics, regional dietary exposure, metabolic heterogeneity, and the potential relevance of pre-intervention microbiota to subsequent treatment outcomes. We also examine how cohort definition, stool sampling, laboratory processing, bioinformatic reconstruction, and statistical analysis shape the microbiome profiles that are ultimately observed. On this basis, we propose a baseline heterogeneity framework built on three linked principles: obesity-associated microbial signals are context-dependent; observed microbiota profiles are method- and pipeline-dependent; and their interpretation must be temporally anchored to the pre-intervention state. This framework positions baseline microbiota profiling not as descriptive cataloging or a search for a universal obesity-specific signature, but as a prerequisite for identifying confounding and effect modification, improving cross-population interpretation, and establishing the microbial and host context from which intervention begins. Future studies should integrate microbiota data with comprehensive characterization of relevant biological and contextual domains and evaluate the robustness of findings across analytical choices and independent populations. This conceptual shift provides a more rigorous foundation for region-specific baseline profiling and future longitudinal, mechanistic, and precision obesity research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.